| |
| |
|
| Insider
Information: |
Congleton Jon |
| Relationship: |
Chief Executive Office... |
| City: |
Boulder |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,069,068 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,294,000 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,069,068 |
|
|
| Total
Value |
$1,294,000 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alpine Immune Sciences Inc |
ALPN |
President and CEO, Dir... |
2016-06-16 |
20,000 |
2015-12-11 |
0 |
Premium* |
|
|
Mineralys Therapeutics, Inc. |
MLYS |
Chief Executive Office... |
2023-11-22 |
1,049,068 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MLYS |
Mineralys Therapeutics, I... |
Chief Executive Officer |
• • – |
2023-11-22 |
4 |
B |
$5.97 |
$25,356 |
D/D |
4,250 |
1,049,068 |
2.81 |
- |
|
| MLYS |
Mineralys Therapeutics, I... |
Chief Executive Officer |
• • – |
2023-09-06 |
4 |
B |
$12.08 |
$27,180 |
D/D |
2,250 |
1,044,818 |
2.81 |
- |
|
| MLYS |
Mineralys Therapeutics, I... |
Chief Executive Officer |
• • – |
2023-08-17 |
4 |
B |
$12.10 |
$27,225 |
D/D |
2,250 |
1,042,568 |
2.81 |
- |
|
| MLYS |
Mineralys Therapeutics, I... |
Chief Executive Officer |
• • – |
2023-08-11 |
4 |
B |
$12.89 |
$25,780 |
D/D |
2,000 |
1,040,318 |
2.81 |
- |
|
| MLYS |
Mineralys Therapeutics, I... |
Chief Executive OfficerOfficer |
• • – |
2023-02-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,038,318 |
|
- |
|
| ALPN |
Alpine Immune Sciences In... |
President and CEO |
• • – |
2016-06-16 |
4 |
B |
$3.87 |
$19,345 |
D/D |
5,000 |
20,000 |
2.81 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
President and CEO |
• • – |
2016-03-24 |
4 |
B |
$4.22 |
$21,085 |
D/D |
5,000 |
15,000 |
2.81 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
President and CEO |
• • – |
2016-03-22 |
4 |
B |
$4.38 |
$21,908 |
D/D |
5,000 |
10,000 |
2.81 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
President and CEO |
• • – |
2015-12-11 |
4 |
B |
$8.10 |
$40,500 |
D/D |
5,000 |
5,000 |
2.81 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
